Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Azacitidine
Related studies linked through entity extraction aliases.
Best Promising Drug Association With Azacitidine in Higher Risk Myelodysplastic Syndromes
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Vidaza (Azacitidine) Versus Support Treatment in Patients With Low Risk Myelodysplastic Syndrome (Low and Intermediate-1 IPSS) Without the 5q Deletion and Transfusion Dependent Anaemia
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Intensified Azacitidine in High Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery
- Status
- WITHDRAWN
- Phase
- NA
Azacitidine in Treating Patients With Previously Treated Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study Examining the Combination of Revlimid (Lenalidomide)and Vidaza (Azacitidine) for Relapsed/Refractory CLL and SLL
- Status
- TERMINATED
- Phase
- PHASE2
Azacitidine in Treating Patients With Chronic Myelomonocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine and Entinostat in Treating Patients With Stage I Non-Small Cell Lung Cancer That Has Been Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE4
Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide
- Status
- TERMINATED
- Phase
- PHASE1
Azacitidine and CAPOX in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Extension to Study AZA PH GL 2003 CL 001 Allowing for Continuation of Azacitidine Treatment in Patients With Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE3
Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine
- Status
- COMPLETED
- Phase
- PHASE2
Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2